VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

9477	Companies
185475	Keywords
117817	Articles
99317	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 02/05/2025 at 07:00, 10 months ago

Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
Valneva receives marketing authorization in the UK for the world's first chikungunya vaccine, IXCHIQ®. Single-dose vaccine for individuals 18+ provides rapid and strong immune response

UK Valneva MHRA Chikungunya Vaccine IXCHIQ®
BRIEF

published on 12/05/2024 at 07:35, 1 year ago

Valneva Reports Share and Voting Rights as of November 30, 2024

Euronext Paris Share Capital Voting Rights Valneva Double Voting
PRESS RELEASE

published on 12/05/2024 at 07:30, 1 year ago

VALNEVA - Declaration of shares and voting rights: November 30, 2024
VALNEVA declares transfer of 1,000 shares into bearer form with double voting rights on November 26, 2024. Total voting rights: 178,371,727

Euronext Paris Voting Rights Shares Stock Market Valneva
BRIEF

published on 12/04/2024 at 10:02, 1 year ago

Polar Capital reduces its stake in VALNEVA SE

Voting Rights Actions Valneva SE Threshold Crossing Polar Capital
BRIEF

published on 12/04/2024 at 07:05, 1 year ago

Valneva Publishes Findings on Chikungunya Impact in British Medical Journal

Climate Change Chikungunya Health Impact Economic Burden Global Study
PRESS RELEASE

published on 12/04/2024 at 07:00, 1 year ago

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
Valneva SE announces the publication of an article on the global health and economic burden of chikungunya in The British Medical Journal, revealing higher disease burden and substantial costs

Valneva SE Global Health Chikungunya Economic Burden British Medical Journal
BRIEF

published on 11/26/2024 at 17:50, 1 year ago

Valneva Seeks FDA Approval for Chikungunya Vaccine Expansion

Valneva FDA Application Chikungunya Vaccine Adolescents Antibody Persistence
PRESS RELEASE

published on 11/26/2024 at 17:45, 1 year ago

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA
Valneva submits label extension application to U.S. FDA for its chikungunya vaccine, IXCHIQ®, to potentially include adolescents aged 12 to 17 years and two-year antibody persistence data

FDA Valneva Chikungunya Vaccine IXCHIQ Label Extension Application
BRIEF

published on 10/10/2024 at 07:05, 1 year 1 month ago

Valneva presents its outlook at an investor day in New York

Investors Growth Valneva Vaccines Lyme
PRESS RELEASE

published on 10/10/2024 at 07:00, 1 year 1 month ago

Valneva Hosts Investor Day in New York City
Valneva SE is hosting an investor day in New York City to discuss key value drivers, including Lyme disease vaccine, commercial vaccines, and R&D pipeline. Hybrid event with webcast and Q&A sessions

Investor Day Valneva SE Lyme Disease Vaccine R&D Pipeline Commercial Vaccines

Accesswire

Published on 12/05/2025 at 14:00, 51 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 51 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 16 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 12 hours 21 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 51 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 14:22, 28 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 34 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 40 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 5 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 51 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting

Les Echos

Published on 12/05/2025 at 08:45, 6 hours 6 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 20 hours 51 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 21 hours 6 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 21 hours 6 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 7 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE